Pharma Mar reported EUR17.34M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.49M 108K Jun/2026
Almirall EUR 217.78M 2.99M Jun/2026
Dianthus Therapeutics USD 54.8M 215.59K Jun/2026
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.62M 13K Sep/2026
Pharma Mar EUR 17.34M 0 Sep/2026
Revvity USD 111.59M 43K Sep/2026
Tectonic Therapeutic USD 19.24M 404.78K Jun/2026
Viatris USD 1.15B 8.79M Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026